Civic Intelligence

American Drug Utilization Review Society

EIN 73-1619985 • 501(c)6 • Edmond, OK

Profile

The mission of american drug utilization review society (adurs) is to provide a forum of leadership and support for the membership to obtain information, develop skills and receive training to efficiently and effectively perform their duties related to drug utilization review.

3006 Edinburg DriveEdmond, OK 73013

www.adurs.com

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

26th percentile

0.00x

Higher debt load relative to assets than 26% of similar nonprofits.

501(c)6 • $500k-$1M nonprofits • Source year 2025

Liabilities / Revenue

28th percentile

0.00x

Higher debt load relative to revenue than 28% of similar nonprofits.

501(c)6 • $500k-$1M nonprofits • Source year 2025

Net Margin

23rd percentile

-6.1%

Higher net margin than 23% of similar nonprofits.

501(c)6 • $500k-$1M nonprofits • Source year 2025

Top Officer Pay

49th percentile

$0

Higher top officer pay than 49% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

501(c)6 • $500k-$1M nonprofits • Source year 2025

Asset Growth

29th percentile

-3.6%

Faster asset growth than 29% of similar nonprofits.

501(c)6 • $500k-$1M nonprofits • Annualized from 2024 to 2025

Revenue Growth

61st percentile

9.4%

Faster revenue growth than 61% of similar nonprofits.

501(c)6 • $500k-$1M nonprofits • Annualized from 2024 to 2025

Balance Sheet
Liabilities / Assets26th percentile

Assets

Down

$553,932

Down $20,772 (-3.6%) from 2024

Liabilities

Up

$194

Up $187 (+2671%) from 2024

Net Assets

Down

$553,738

Down $20,959 (-3.6%) from 2024

Operations
Liabilities / Revenue28th percentileNet Margin23rd percentile

Revenue

Up

$282,430

Up $24,368 (+9.4%) from 2024

Expenses

Up

$299,542

Up $66,672 (+29%) from 2024

Net Income

Down

-$17,112

Down $42,304 (-168%) from 2024

Trend Graphs

Balance Sheet Trend

Asset Growth29th percentile

Grouped bars show assets, liabilities, and net assets across loaded filings.

$800K$600K$400K$200K$0Assets 2012: $386,728Liabilities 2012: $3,002Net Assets 2012: $383,7262012Assets 2013: $372,569Liabilities 2013: $3,633Net Assets 2013: $368,9362013Assets 2014: $430,332Liabilities 2014: $7,972Net Assets 2014: $422,3602014Assets 2015: $487,267Liabilities 2015: $3,478Net Assets 2015: $483,7892015Assets 2016: $590,133Liabilities 2016: $81,271Net Assets 2016: $508,8622016Assets 2017: $582,501Liabilities 2017: $2,036Net Assets 2017: $580,4652017Assets 2018: $626,074Liabilities 2018: $1,343Net Assets 2018: $624,7312018Assets 2019: $635,765Liabilities 2019: $1,299Net Assets 2019: $634,4662019Assets 2020: $626,060Liabilities 2020: $1,259Net Assets 2020: $624,8012020Assets 2021: $693,114Liabilities 2021: $956Net Assets 2021: $692,1582021Assets 2022: $647,744Liabilities 2022: $425Net Assets 2022: $647,3192022Assets 2023: $522,688Liabilities 2023: $328Net Assets 2023: $522,3602023Assets 2024: $574,704Liabilities 2024: $7Net Assets 2024: $574,6972024Assets 2025: $553,932Liabilities 2025: $194Net Assets 2025: $553,7382025

Highlighted filing

2025

Assets$553,932
Liabilities$194
Net Assets$553,738
Open 2025 Filing

Operations Trend

Revenue Growth61st percentile

Revenue, expenses, and net income by year, with the latest filing highlighted.

$400K$200K$0-$200KRevenue 2012: $154,761Expenses 2012: $184,347Net Income 2012: -$29,5862012Revenue 2013: $153,327Expenses 2013: $168,117Net Income 2013: -$14,7902013Revenue 2014: $248,116Expenses 2014: $194,692Net Income 2014: $53,4242014Revenue 2015: $267,104Expenses 2015: $205,675Net Income 2015: $61,4292015Revenue 2016: $250,553Expenses 2016: $207,609Net Income 2016: $42,9442016Revenue 2017: $262,930Expenses 2017: $210,335Net Income 2017: $52,5952017Revenue 2018: $229,963Expenses 2018: $201,758Net Income 2018: $28,2052018Revenue 2019: $238,192Expenses 2019: $225,757Net Income 2019: $12,4352019Revenue 2020: $238,249Expenses 2020: $205,264Net Income 2020: $32,9852020Revenue 2021: $71,209Expenses 2021: $108,672Net Income 2021: -$37,4632021Revenue 2022: $250,239Expenses 2022: $230,138Net Income 2022: $20,1012022Revenue 2023: $237,818Expenses 2023: $346,779Net Income 2023: -$108,9612023Revenue 2024: $258,062Expenses 2024: $232,870Net Income 2024: $25,1922024Revenue 2025: $282,430Expenses 2025: $299,542Net Income 2025: -$17,1122025

Highlighted filing

2025

Revenue$282,430
Expenses$299,542
Net Income-$17,112
Open 2025 Filing

Filings

Most recent year

2025 • Form 990Facts available. Structured filing facts are available, but richer extracted sections are limited.

Open filing
Assets
$553,932
Liabilities
$194
Net assets
$553,738
Revenue
$282,430
Expenses
$299,542
Net income
-$17,112
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2025Facts available. Structured filing facts are available, but richer extracted sections are limited.$5.54$0.00$5.54$2.82$3.00$0.17
2024Detailed filing. Detailed filing data is available for this year.$5.75$0.00$5.75$2.58$2.33$0.25
2023Detailed filing. Detailed filing data is available for this year.$5.23$0.00$5.22$2.38$3.47$1.09
2022Detailed filing. Detailed filing data is available for this year.$6.48$0.00$6.47$2.50$2.30$0.20
2021Detailed filing. Detailed filing data is available for this year.$6.93$0.01$6.92$0.71$1.09$0.37
2020Detailed filing. Detailed filing data is available for this year.$6.26$0.01$6.25$2.38$2.05$0.33
2019Detailed filing. Detailed filing data is available for this year.$6.36$0.01$6.34$2.38$2.26$0.12
2018Detailed filing. Detailed filing data is available for this year.$6.26$0.01$6.25$2.30$2.02$0.28
2017Detailed filing. Detailed filing data is available for this year.$5.83$0.02$5.80$2.63$2.10$0.53
2016Summary only. Only limited summary data is available for this year.$5.90$0.81$5.09$2.51$2.08$0.43
2015Summary only. Only limited summary data is available for this year.$4.87$0.03$4.84$2.67$2.06$0.61
2014Summary only. Only limited summary data is available for this year.$4.30$0.08$4.22$2.48$1.95$0.53
2013Summary only. Only limited summary data is available for this year.$3.73$0.04$3.69$1.53$1.68$0.15
2012Summary only. Only limited summary data is available for this year.$3.87$0.03$3.84$1.55$1.84$0.30
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
May 1, 2024 to Apr 30, 2025
Signed
Sep 25, 2025
Return Version
2024v5.0
Gross Receipts
$282,430
Mission and Program Overview

Mission

The mission of american drug utilization review society (adurs) is to provide a forum of leadership and support for the membership to obtain information, develop skills and receive training to efficiently and effectively perform their duties related to drug utilization review.

American drug utilization review society (adurs) is a non-profit entity supporting individuals active in drug utilization review. Each year, a conference is organized by adurs to provide updates for state medicaid programs where members share information, develop skills and obtain training.

Balance Sheet Detail
LineBeginningEndChange
Assets
Investments in Publicly Traded Securities$521,626$479,804▼ $41,822
Cash and Non-Interest-Bearing Accounts$51,816$73,405▲ $21,589
Land, Buildings, and Equipment, Net$1,262$723▼ $539
Total Assets$574,704$553,932▼ $20,772
Liabilities
Other Liabilities$7$194▲ $187
Total Liabilities$7$194▲ $187
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$574,697$553,738▼ $20,959
Total Net Assets Fund Balance$574,697$553,738▼ $20,959
Total Liabilities and Net Assets / Fund Balance$574,704$553,932▼ $20,772

Asset Categories

AssetBook ValueDepreciationBasis
Equipment$723$8,585-
Compensation and Service Providers
Top Officer Pay49th percentile

Board Members and Trustees

NameTitle
Amanda KiriakopoulosDirector at
Shellie KeastExecutive Di
Terry CothranProgram Comm
Aimee LewisSecretary
Pamela SmithTreasurer
Revenue and Support

Revenue Composition

Contributions and Grants
$0
Program Service Revenue
$244,700
Investment Income
$37,730
Other Revenue
$0
Change in Net Assets
$-17,112
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$268,496
Salaries, Compensation, and Employee Benefits$31,046
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Conferences and Meetings---$251,331
Other Salaries and Wages---$28,826
Office Expenses---$5,227
Information Technology---$4,038
Insurance---$2,901
Fees for Services Accounting---$2,700
Payroll Taxes---$2,220
Depreciation Depletion---$539
Other Expenses---$5
Total Functional Expenses$0$0$0$299,542
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Subject to proxy tax
No
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Credit Cards Payable$194
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
Yes
Audit committee
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
No
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Page 6, Part VI, Line 11B

“The annual form 990 is prepared by an independent accountant. A copy of the completed return is provided to the organization board for review prior to filing the return. Approval by the board is obtained prior to filing the return.”

Form 990, Page 6, Part VI, Line 19

“No documents available to the public”

Filing and Contact Details

Filer

Filer Name
American Drug Utilization Review
EIN
73-1619985
Phone
4053582472
Address
3006 EDINBURG DRIVE, EDMOND, OK 73013

Signing Officer

Name
Shellie Keast
Title
Executive Director
Phone
4053582472
Signed
2025-09-25
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Shellie Keast
Formed
2001
Legal Domicile
Ok
Voting Board Members
4
Independent Board Members
4
Employees
2
Volunteers
25

Preparer

Firm
Steven M Phelan CPA Pllc
Address
PO BOX 1197, MUSTANG, OK 73064-1197
Preparer
Steven M Phelan
Phone
4056331694
Supplemental Narrative

Additional Explanations

FORM 990 - ORGANIZATION'S MISSION

“The mission of american drug utilization review society (adurs) is to provide a forum of leadership and support for the membership to obtain information, develop skills and receive training to efficiently and effectively perform their duties related to drug utilization review.”

Raw XML Appendix282 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd0true
IRS990/AcctCompileOrReviewBasisGrp/SeparateBasisFinclStmtInd0X
IRS990/ActivitiesConductedPrtshpInd0false
IRS990/ActivityOrMissionDesc0AMERICAN DRUG UTILIZATION REVIEW SOCIETY (ADURS) IS A NON-PROFIT ENTITY SUPPORTING INDIVIDUALS ACTIVE IN DRUG UTILIZATION REVIEW. EACH YEAR, A CONFERENCE IS ORGANIZED BY ADURS TO PROVIDE UPDATES FOR STATE MEDICAID PROGRAMS WHERE MEMBERS SHARE INFORMATION, DEVELOP SKILLS AND OBTAIN TRAINING.
IRS990/AuditCommitteeInd0true
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0STEVEN M PHELAN CPA PLLC
IRS990/BooksInCareOfDetail/PhoneNum04056331694
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt0PO BOX 1197
IRS990/BooksInCareOfDetail/USAddress/CityNm0MUSTANG
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0OK
IRS990/BooksInCareOfDetail/USAddress/ZIPCd073064
IRS990/BusinessRlnWith35CtrlEntInd0false
IRS990/BusinessRlnWithFamMemInd0false
IRS990/BusinessRlnWithOrgMemInd0false
IRS990/CashNonInterestBearingGrp/BOYAmt051816
IRS990/CashNonInterestBearingGrp/EOYAmt073405
IRS990/ChangeToOrgDocumentsInd0false
IRS990/CollectionsOfArtInd0false
IRS990/CompensationFromOtherSrcsInd0false
IRS990/CompensationProcessCEOInd0false
IRS990/CompensationProcessOtherInd0false
IRS990/ConferencesMeetingsGrp/TotalAmt0251331
IRS990/ConflictOfInterestPolicyInd0false
IRS990/ConservationEasementsInd0false
IRS990/ConsolidatedAuditFinclStmtInd0false
IRS990/CreditCounselingInd0false
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt00
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt037730
IRS990/CYOtherExpensesAmt0268496
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt0244700
IRS990/CYRevenuesLessExpensesAmt0-17112
IRS990/CYSalariesCompEmpBnftPaidAmt031046
IRS990/CYTotalExpensesAmt0299542
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt0282430
IRS990/DecisionsSubjectToApprovaInd0false
IRS990/DeductibleArtContributionInd0false
IRS990/DeductibleNonCashContriInd0false
IRS990/DelegationOfMgmtDutiesInd0false
IRS990/DepreciationDepletionGrp/TotalAmt0539
IRS990/Desc0EACH YEAR, A SYMPOSIUM IS ORGANIZED BY AMERICAN DRUG UTILIZATION REVIEW SOCIETY (ADURS) TO PROVIDE UPDATES FOR STATE MEDICAID PROGRAMS WHERE MEMBERS SHARE INFORMATION, DEVELOP SKILLS AND OBTAIN TRAINING. THE SYMPOSIUM AVERAGES AROUND 120 INDIVIDUALS REPRESENTING AN AVERAGE OF 43 STATE MEDICAID PROGRAMS. ATTENDEES EARN ACPE APPROVED CONTINUING EDUCATION CREDITS UPON COMPLETION OF THE SYMPOSIUM.
IRS990/DescribedInSection501c3Ind0false
IRS990/DisregardedEntityInd0false
IRS990/DocumentRetentionPolicyInd0false
IRS990/DonorAdvisedFundInd0false
IRS990/DonorRstrOrQuasiEndowmentsInd0false
IRS990/ElectionOfBoardMembersInd0false
IRS990/EmployeeCnt02
IRS990/EmploymentTaxReturnsFiledInd0true
IRS990/FamilyOrBusinessRlnInd0false
IRS990/FederalGrantAuditRequiredInd0false
IRS990/FeesForServicesAccountingGrp/TotalAmt02700
IRS990/ForeignActivitiesInd0false
IRS990/ForeignFinancialAccountInd0false
IRS990/ForeignOfficeInd0false
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt01.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt45.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd3X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/PersonNm0TERRY COTHRAN
IRS990/Form990PartVIISectionAGrp/PersonNm1AMANDA KIRIAKOPOULOS
IRS990/Form990PartVIISectionAGrp/PersonNm2AIMEE LEWIS
IRS990/Form990PartVIISectionAGrp/PersonNm3PAMELA SMITH
IRS990/Form990PartVIISectionAGrp/PersonNm4SHELLIE KEAST
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/TitleTxt0PROGRAM COMM
IRS990/Form990PartVIISectionAGrp/TitleTxt1DIRECTOR AT
IRS990/Form990PartVIISectionAGrp/TitleTxt2SECRETARY
IRS990/Form990PartVIISectionAGrp/TitleTxt3TREASURER
IRS990/Form990PartVIISectionAGrp/TitleTxt4EXECUTIVE DI
IRS990/Form990ProvidedToGvrnBodyInd0true
IRS990/FormationYr02001
IRS990/FormerOfcrEmployeesListedInd0false
IRS990/FSAuditedInd0false
IRS990/FundraisingActivitiesInd0false
IRS990/GamingActivitiesInd0false
IRS990/GoverningBodyVotingMembersCnt04
IRS990/GrantsToIndividualsInd0false
IRS990/GrantsToOrganizationsInd0false
IRS990/GrantToRelatedPersonInd0false
IRS990/GrossReceiptsAmt0282430
IRS990/GroupReturnForAffiliatesInd0false
IRS990/IncludeFIN48FootnoteInd0false
IRS990/IndependentAuditFinclStmtInd0false
IRS990/IndependentVotingMemberCnt04
IRS990/IndoorTanningServicesInd0false
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InformationTechnologyGrp/TotalAmt04038
IRS990/InsuranceGrp/TotalAmt02901
IRS990/InvestmentIncomeGrp/ExclusionAmt037730
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt037730
IRS990/InvestmentInJointVentureInd0false
IRS990/InvestmentsPubTradedSecGrp/BOYAmt0521626
IRS990/InvestmentsPubTradedSecGrp/EOYAmt0479804
IRS990/IRPDocumentCnt01
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt08585
IRS990/LandBldgEquipBasisNetGrp/BOYAmt01262
IRS990/LandBldgEquipBasisNetGrp/EOYAmt0723
IRS990/LandBldgEquipCostOrOtherBssAmt09308
IRS990/LegalDomicileStateCd0OK
IRS990/LoanOutstandingInd0false
IRS990/LocalChaptersInd0false
IRS990/MaterialDiversionOrMisuseInd0false
IRS990/MembersOrStockholdersInd0false
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd0true
IRS990/MinutesOfGoverningBodyInd0true
IRS990/MissionDesc0THE MISSION OF AMERICAN DRUG UTILIZATION REVIEW SOCIETY (ADURS) IS TO PROVIDE A FORUM OF LEADERSHIP AND SUPPORT FOR THE MEMBERSHIP TO OBTAIN INFORMATION, DEVELOP SKILLS AND RECEIVE TRAINING TO EFFICIENTLY AND EFFECTIVELY PERFORM THEIR DUTIES RELATED TO DRUG UTILIZATION REVIEW.
IRS990/MoreThan5000KToIndividualsInd0false
IRS990/MoreThan5000KToOrgInd0false
IRS990/NetAssetsOrFundBalancesBOYAmt0574697
IRS990/NetAssetsOrFundBalancesEOYAmt0553738
IRS990/NetUnrlzdGainsLossesInvstAmt0-3847
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt0574697
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt0553738
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NondeductibleContributionsInd0false
IRS990/OfficeExpensesGrp/TotalAmt05227
IRS990/OfficerMailingAddressInd0false
IRS990/OperateHospitalInd0false
IRS990/Organization501cInd0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherExpensesGrp/Desc0DUES & SUBSCRIPTIONS
IRS990/OtherExpensesGrp/Desc1EDUCATION & TRAINING
IRS990/OtherExpensesGrp/Desc2PAYROLL PROCESSING FEES
IRS990/OtherExpensesGrp/Desc3BANK SERVICE CHARGES
IRS990/OtherExpensesGrp/TotalAmt0948
IRS990/OtherExpensesGrp/TotalAmt1750
IRS990/OtherExpensesGrp/TotalAmt257
IRS990/OtherExpensesGrp/TotalAmt35
IRS990/OtherLiabilitiesGrp/BOYAmt07
IRS990/OtherLiabilitiesGrp/EOYAmt0194
IRS990/OtherSalariesAndWagesGrp/TotalAmt028826
IRS990/PartialLiquidationInd0false
IRS990/PayrollTaxesGrp/TotalAmt02220
IRS990/PoliticalCampaignActyInd0false
IRS990/PrincipalOfficerNm0SHELLIE KEAST
IRS990/ProfessionalFundraisingInd0false
IRS990/ProgramServiceRevenueGrp/Desc0CORPORATE SPONSORSHIPS
IRS990/ProgramServiceRevenueGrp/Desc1CONFERENCE REGISTRATIONS
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt0220000
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt124700
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt0220000
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt124700
IRS990/ProhibitedTaxShelterTransInd0false
IRS990/PYInvestmentIncomeAmt017277
IRS990/PYOtherExpensesAmt0204854
IRS990/PYProgramServiceRevenueAmt0240785
IRS990/PYRevenuesLessExpensesAmt025192
IRS990/PYSalariesCompEmpBnftPaidAmt028016
IRS990/PYTotalExpensesAmt0232870
IRS990/PYTotalRevenueAmt0258062
IRS990/ReconcilationRevenueExpnssAmt0-17112
IRS990/RelatedEntityInd0false
IRS990/RelatedOrganizationCtrlEntInd0false
IRS990/ReportInvestmentsOtherSecInd0false
IRS990/ReportLandBuildingEquipmentInd0true
IRS990/ReportOtherAssetsInd0false
IRS990/ReportOtherLiabilitiesInd0true
IRS990/ReportProgramRelatedInvstInd0false
IRS990/ScheduleBRequiredInd0false
IRS990ScheduleD/EquipmentGrp/BookValueAmt0723
IRS990ScheduleD/EquipmentGrp/DepreciationAmt08585
IRS990ScheduleD/EquipmentGrp/InvestmentCostOrOtherBasisAmt09308
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt0194
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc0CREDIT CARDS PAYABLE
IRS990ScheduleD/TotalBookValueLandBuildingsAmt0723
IRS990ScheduleD/TotalLiabilityAmt0194
IRS990/ScheduleJRequiredInd0false
IRS990/ScheduleORequiredInd0false
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0THE MISSION OF AMERICAN DRUG UTILIZATION REVIEW SOCIETY (ADURS) IS TO PROVIDE A FORUM OF LEADERSHIP AND SUPPORT FOR THE MEMBERSHIP TO OBTAIN INFORMATION, DEVELOP SKILLS AND RECEIVE TRAINING TO EFFICIENTLY AND EFFECTIVELY PERFORM THEIR DUTIES RELATED TO DRUG UTILIZATION REVIEW.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1THE ANNUAL FORM 990 IS PREPARED BY AN INDEPENDENT ACCOUNTANT. A COPY OF THE COMPLETED RETURN IS PROVIDED TO THE ORGANIZATION BOARD FOR REVIEW PRIOR TO FILING THE RETURN. APPROVAL BY THE BOARD IS OBTAINED PRIOR TO FILING THE RETURN.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2NO DOCUMENTS AVAILABLE TO THE PUBLIC
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990 - ORGANIZATION'S MISSION
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990, PAGE 6, PART VI, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990, PAGE 6, PART VI, LINE 19
IRS990/SchoolOperatingInd0false
IRS990/SignificantChangeInd0false
IRS990/SignificantNewProgramSrvcInd0false
IRS990/StatesWhereCopyOfReturnIsFldCd0OK
IRS990/SubjectToExcsTaxNetInvstIncInd0false
IRS990/SubjectToProxyTaxInd0false
IRS990/SubjToTaxRmnrtnExPrchtPymtInd0false
IRS990/TaxablePartyNotificationInd0false
IRS990/TaxExemptBondsInd0false
IRS990/TerminateOperationsInd0false
IRS990/TotalAssetsBOYAmt0574704
IRS990/TotalAssetsEOYAmt0553932
IRS990/TotalAssetsGrp/BOYAmt0574704
IRS990/TotalAssetsGrp/EOYAmt0553932
IRS990/TotalCompGreaterThan150KInd0false
IRS990/TotalEmployeeCnt02
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt00
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt00
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt00
IRS990/TotalFunctionalExpensesGrp/TotalAmt0299542
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesBOYAmt07
IRS990/TotalLiabilitiesEOYAmt0194
IRS990/TotalLiabilitiesGrp/BOYAmt07
IRS990/TotalLiabilitiesGrp/EOYAmt0194
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt0574697
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt0553738
IRS990/TotalProgramServiceRevenueAmt0244700
IRS990/TotalRevenueGrp/ExclusionAmt037730
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt0244700
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt0282430
IRS990/TotalVolunteersCnt025
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt0574704
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt0553932
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd0false
IRS990/UponRequestInd0X
IRS990/USAddress/AddressLine1Txt03006 EDINBUG DRIVE
IRS990/USAddress/CityNm0EDMOND
IRS990/USAddress/StateAbbreviationCd0OK
IRS990/USAddress/ZIPCd073013
IRS990/VotingMembersGoverningBodyCnt04
IRS990/VotingMembersIndependentCnt04
IRS990/WebsiteAddressTxt0HTTP://WWW.ADURS.COM/
IRS990/WhistleblowerPolicyInd0false
ReturnHeader/BuildTS02025-03-06 01:10:19Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0SHELLIE KEAST
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0EXECUTIVE DIRECTOR
ReturnHeader/BusinessOfficerGrp/PhoneNum04053582472
ReturnHeader/BusinessOfficerGrp/SignatureDt02025-09-25
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0AMERICAN DRUG UTILIZATION REVIEW
ReturnHeader/Filer/BusinessName/BusinessNameLine2Txt0SOCIETY
ReturnHeader/Filer/BusinessNameControlTxt0AMER
ReturnHeader/Filer/EIN0731619985
ReturnHeader/Filer/PhoneNum04053582472
ReturnHeader/Filer/USAddress/AddressLine1Txt03006 EDINBURG DRIVE
ReturnHeader/Filer/USAddress/CityNm0EDMOND
ReturnHeader/Filer/USAddress/StateAbbreviationCd0OK
ReturnHeader/Filer/USAddress/ZIPCd073013
ReturnHeader/IRSResponsiblePrtyInfoCurrInd0false
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0461932715
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0STEVEN M PHELAN CPA PLLC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt0PO BOX 1197
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0MUSTANG
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0OK
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd0730641197
ReturnHeader/PreparerPersonGrp/PhoneNum04056331694
ReturnHeader/PreparerPersonGrp/PreparationDt02025-09-25
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0STEVEN M PHELAN
ReturnHeader/PreparerPersonGrp/SelfEmployedInd0X
ReturnHeader/ReturnTs02025-09-25T20:08:32-04:00
ReturnHeader/ReturnTypeCd0990
ReturnHeader/TaxPeriodBeginDt02024-05-01
ReturnHeader/TaxPeriodEndDt02025-04-30
ReturnHeader/TaxYr02024

Document Assets

No mirrored PDF or thumbnail assets are attached yet.